Safety of COVID-19 vaccine challenge in patients with immediate adverse reactions to prior doses: A multi-centre cohort study

Allergy. 2023 Jan;78(1):293-296. doi: 10.1111/all.15467. Epub 2022 Aug 9.

Joseph F De Luca^{1

2}, Andrew Awad¹, Sara Vogrin³, Abby P Douglas¹, Antje Lutjen⁴, Sally F Gordon⁵, Nigel W Crawford^{6

7}, Sara Barnes⁴, Jason A Trubiano^{1

2}

¹ Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Vic., Australia.
² Department of Medicine, University of Melbourne, Melbourne, Vic., Australia.
³ Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Vic., Australia.
⁴ Department of Allergy, Monash Health, Clayton, Vic., Australia.
⁵ Vaccine Safety and Evaluation, COVID-19 Vaccination Program, Victorian Department of Health, Melbourne, Vic., Australia.
⁶ SAEFVIC, Victorian Vaccine Safety Service, MCRI, Parkville, Vic., Australia.
⁷ Department of Paediatrics, University of Melbourne, Melbourne, Vic., Australia.

No abstract available

Keywords: COVID-19; SARS-CoV-2; allergy; challenge; vaccine.

Publication types